Presently recommended biomarkers for lung cancer include carcinoembryonic antigen (CEA), progastrin‐releasing peptide (ProGRP), cytokeratin 19 fragment (Cyfra21‐1), neuron‐specific enolase (NSE), and squamous cell carcinoma antigen (SCC). Here, ENO2 is linked to lung cancer.